logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ASCO 2019 — Frontline pembrolizumab offers alternative to chemotherapy in gastric/gastroesophageal junction cancers

Gastric cancer is the fifth most frequently diagnosed cancer worldwide, with a poor outcome after surgery.